Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Research

Sweep imaging with Fourier transform as a tool with MRI for evaluating the effect of teriparatide on cortical bone formation in an ovariectomized rat model

Authors: Yasutaka Sotozono, Kazuya Ikoma, Masamitsu Kido, Okihiro Onishi, Masataka Minami, Hiroaki Wada, Shunji Yamada, Ken-Ichi Matsuda, Masaki Tanaka, Kenji Takahashi

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Background

Teriparatide (TPTD) is a drug for osteoporosis that promotes bone formation and improves bone quality. However, the effects of TPTD on cortical bone are not well understood. Sweep imaging with Fourier transform (SWIFT) has been reported as a useful tool for evaluating bound water of cortical bone, but it has yet to be used to investigate the effects of TPTD on cortical bone. This study aimed to evaluate the consequences of the effect of TPTD on cortical bone formation using SWIFT.

Methods

Twelve-week-old female Sprague-Dawley rats (n = 36) were reared after ovariectomy to create a postmenopausal osteoporosis model. They were divided into two groups: the TPTD and non-TPTD groups. Rats were euthanized at 4, 12, and 24 weeks after initiating TPTD treatment. Tibial bones were evaluated using magnetic resonance imaging (MRI) and bone histomorphometry. In MRI, proton density-weighted imaging (PDWI) and SWIFT imaging were performed. The signal-to-noise ratio (SNR) was calculated for each method. The same area evaluated by MRI was then used to calculate the bone formation rate by bone histomorphometry. Measurements were compared using the Mann-Whitney U-test, and a P-value of < 0.05 was considered significant.

Results

PDWI-SNR was not significantly different between the two groups at any time point (P = 0.589, 0.394, and 0.394 at 4, 12, and 24 weeks, respectively). Contrarily, SWIFT-SNR was significantly higher in the TPTD group than in the non-TPTD group at 4 weeks after initiating treatment, but it was not significantly different at 12 and 24 weeks (P = 0.009, 0.937, and 0.818 at 4, 12, and 24 weeks, respectively). The bone formation rate assessed by histomorphometry was significantly higher in the TPTD group than in the non-TPTD group at all timepoints (P < 0.05, all weeks). In particular, at 4 weeks, the bone formation rate was markedly higher in the TPTD group than in the non-TPTD group (P = 0.028, 1.98 ± 0.33 vs. 0.09 ± 0.05 μm3/μm2/day).

Conclusions

SWIFT could detect increased signals of bound water, reflecting the effect of TPTD on the cortical bone. The signal detected by SWIFT reflects a marked increase in the cortical bone formation rate.
Literature
1.
go back to reference NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-95. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-95.
2.
go back to reference Melton LJ 3rd, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL. Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 1997;12:1083–91.CrossRef Melton LJ 3rd, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL. Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 1997;12:1083–91.CrossRef
3.
go back to reference Gambert SR, Schultz BM, Hamdy RC. Osteoporosis clinical features, prevention, and treatment. Endocrinol Metab Clin N Am. 1995;24:317–71.CrossRef Gambert SR, Schultz BM, Hamdy RC. Osteoporosis clinical features, prevention, and treatment. Endocrinol Metab Clin N Am. 1995;24:317–71.CrossRef
4.
go back to reference Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337–49.CrossRef Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337–49.CrossRef
5.
go back to reference Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, et al. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int. 1999;9:296–306.CrossRef Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, et al. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int. 1999;9:296–306.CrossRef
6.
go back to reference Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy. Bone Miner. 1988;3:193–9.PubMed Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy. Bone Miner. 1988;3:193–9.PubMed
7.
go back to reference Sugimoto T, Nakamura T, Nakamura Y, Isogai Y, Shiraki M. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis. Osteoporos Int. 2014;25:1173–80.CrossRef Sugimoto T, Nakamura T, Nakamura Y, Isogai Y, Shiraki M. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis. Osteoporos Int. 2014;25:1173–80.CrossRef
8.
go back to reference Holzer G, von Skrbensky G, Holzer LA, Pichl W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009;24:468–74.CrossRef Holzer G, von Skrbensky G, Holzer LA, Pichl W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res. 2009;24:468–74.CrossRef
9.
go back to reference Rockoff SD, Sweet E, Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969;3:163–75.CrossRef Rockoff SD, Sweet E, Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969;3:163–75.CrossRef
10.
go back to reference Idiyatullin D, Corum C, Park JY, Garwood M. Fast and quiet MRI using a swept radiofrequency. J Magn Reson. 2006;181:342–9.CrossRef Idiyatullin D, Corum C, Park JY, Garwood M. Fast and quiet MRI using a swept radiofrequency. J Magn Reson. 2006;181:342–9.CrossRef
11.
go back to reference Sukenari T, Horii M, Ikoma K, Kido M, Hayashi S, Hara Y, et al. Cortical bone water changes in ovariectomized rats during the early postoperative period: objective evaluation using sweep imaging with Fourier transform. J Magn Reson Imaging. 2015;42:128–35.CrossRef Sukenari T, Horii M, Ikoma K, Kido M, Hayashi S, Hara Y, et al. Cortical bone water changes in ovariectomized rats during the early postoperative period: objective evaluation using sweep imaging with Fourier transform. J Magn Reson Imaging. 2015;42:128–35.CrossRef
12.
go back to reference Minami M, Ikoma K, Horii M, Sukenari T, Onishi O, Fujiwara H, et al. Usefulness of sweep imaging with Fourier transform for evaluation of cortical bone in diabetic rats. J Magn Reson Imaging. 2018;48:389–97.CrossRef Minami M, Ikoma K, Horii M, Sukenari T, Onishi O, Fujiwara H, et al. Usefulness of sweep imaging with Fourier transform for evaluation of cortical bone in diabetic rats. J Magn Reson Imaging. 2018;48:389–97.CrossRef
13.
go back to reference Weiger M, Pruessmann KP, Hennel F. MRI with zero echo time: hard versus sweep pulse excitation. Magn Reson Med. 2011;66:379–89.CrossRef Weiger M, Pruessmann KP, Hennel F. MRI with zero echo time: hard versus sweep pulse excitation. Magn Reson Med. 2011;66:379–89.CrossRef
14.
go back to reference Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991;15:175–91.CrossRef Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991;15:175–91.CrossRef
15.
go back to reference Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry nomenclature committee. J Bone Miner Res. 1987;2:595–610.CrossRef Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry nomenclature committee. J Bone Miner Res. 1987;2:595–610.CrossRef
16.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
17.
go back to reference Cullum ID, Ell PJ, Ryder JP. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol. 1989;62:587–92.CrossRef Cullum ID, Ell PJ, Ryder JP. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol. 1989;62:587–92.CrossRef
18.
go back to reference Kishi T, Hagino H, Kishimoto H, Nagashima H. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration. Bone. 1998;22:515–22.CrossRef Kishi T, Hagino H, Kishimoto H, Nagashima H. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration. Bone. 1998;22:515–22.CrossRef
19.
go back to reference Müller R, Van Campenhout H, Van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone. 1998;23:59–66.CrossRef Müller R, Van Campenhout H, Van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone. 1998;23:59–66.CrossRef
20.
go back to reference Ito M, Oishi R, Fukunaga M, Sone T, Sugimoto T, Shiraki M, et al. The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT. Osteoporos Int. 2014;25:1163–72.CrossRef Ito M, Oishi R, Fukunaga M, Sone T, Sugimoto T, Shiraki M, et al. The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT. Osteoporos Int. 2014;25:1163–72.CrossRef
21.
go back to reference Horch RA, Nyman JS, Gochberg DF, Dortch RD, Does MD. Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging. Magn Reson Med. 2010;64:680–7.CrossRef Horch RA, Nyman JS, Gochberg DF, Dortch RD, Does MD. Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging. Magn Reson Med. 2010;64:680–7.CrossRef
22.
go back to reference Du J, Bydder GM. Qualitative and quantitative ultrashort-TE MRI of cortical bone. NMR Biomed. 2013;26:489–506.CrossRef Du J, Bydder GM. Qualitative and quantitative ultrashort-TE MRI of cortical bone. NMR Biomed. 2013;26:489–506.CrossRef
23.
go back to reference Wronski TJ, Yen CF. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone. 1994;15:51–8.CrossRef Wronski TJ, Yen CF. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone. 1994;15:51–8.CrossRef
24.
go back to reference Robinson RA. An electron-microscopic study of the crystalline inorganic component of bone and its relationship to the organic matrix. J Bone Joint Surg Am. 1952;34-A(2):389-435. Robinson RA. An electron-microscopic study of the crystalline inorganic component of bone and its relationship to the organic matrix. J Bone Joint Surg Am. 1952;34-A(2):389-435.
25.
go back to reference Zebaze R, Takao-Kawabata R, Peng Y. Increased cortical porosity is associated with daily, not weekly, administration of equivalent doses of teriparatide. Bone. 2017;99:80–4.CrossRef Zebaze R, Takao-Kawabata R, Peng Y. Increased cortical porosity is associated with daily, not weekly, administration of equivalent doses of teriparatide. Bone. 2017;99:80–4.CrossRef
26.
go back to reference Hodsman AB, Kisiel M, Adachi JD. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone. 2000;27:311–8.CrossRef Hodsman AB, Kisiel M, Adachi JD. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone. 2000;27:311–8.CrossRef
27.
go back to reference Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R. Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab. 2015;100:4662–8.CrossRef Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R. Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab. 2015;100:4662–8.CrossRef
28.
go back to reference Al Badr W, Martin KJ. Role of bone biopsy in renal osteodystrophy. Saudi J Kidney Dis Transpl. 2009;20:12–9.PubMed Al Badr W, Martin KJ. Role of bone biopsy in renal osteodystrophy. Saudi J Kidney Dis Transpl. 2009;20:12–9.PubMed
Metadata
Title
Sweep imaging with Fourier transform as a tool with MRI for evaluating the effect of teriparatide on cortical bone formation in an ovariectomized rat model
Authors
Yasutaka Sotozono
Kazuya Ikoma
Masamitsu Kido
Okihiro Onishi
Masataka Minami
Hiroaki Wada
Shunji Yamada
Ken-Ichi Matsuda
Masaki Tanaka
Kenji Takahashi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-021-04970-7

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue